Sanner introduces bio-based plastic packaging

Represents the first biopackaging of its kind made of renewable raw materials.
At Pharmapack 2020, Sanner will focus on sustainability and will debut its new Sanner BioBase effervescent tablet packaging. Sanner BioBase is the first biopackaging of its kind made of renewable raw materials.
Sanner BioBase is the first effervescent tablet packaging that consists of more than 90% bio-based material. The biopolymers used consist of various renewable raw materials such as corn, sugar cane or cellulose, which are converted into "green" ethanol. A major advantage of bio-based plastic packaging is its essential independence from fossil raw material deposits and its reduced CO2 footprint. Bio-based plastic packaging has the same properties as conventional packaging solutions. They can also be processed on existing filling lines. From a chemical point of view, Sanner BioBase is almost identical to PE and PP from fossil raw materials.
High-quality and climate-friendly
"Sanner BioBase can be recycled, increases resource efficiency and makes it easier for us to achieve our climate targets," says Ursula Hahn, Head of Product Management at Sanner. Another important argument for customers and consumers is the extended shelf life of the tablets thanks to higher H2O barrier properties. In terms of handling, Sanner BioBase offers consumers a high-quality feel and appearance. The tablet tube can be printed or provided with an IML label.
Sanner BioBase will be commercially available from the second quarter of 2020. The initial tablet tube will have a diameter of 27 millimeters and can be combined with the appropriate desiccant closure. "The solution is currently aimed primarily at food supplement producers," says Ursula Hahn. "Due to the stricter regulations in the pharmaceutical industry, this market will be our next focus".
Sustainability and innovation as part of the corporate DNA
Sanner launched the first desiccant closure for moisture-sensitive tablets 60 years ago and became the market leader for both desiccant and effervescent tablet packaging. "We are continuing this tradition with continuous development work and with the first bio-based effervescent tablet packaging," says Peik-Christian Witte, Director R&D at Sanner. The company’s corporate culture is based on innovation and sustainability: Sanner has been investing in the optimization of its own manufacturing processes for many years. For example, the Bensheim site uses its own combined heat and power generation system. In recent years, the company has been able to significantly reduce CO2 emissions and energy consumption for the production of plastic packaging.
TabTec CR tablet container: child-resistant and senior-friendly
Also on show at Pharmapack: the TabTec CR tablet container, which was launched at the end of 2019 and will also be showcased in the Pharmapack Innovation Gallery. The innovative opening mechanism protects children from accidentally taking painkillers, antidepressants or medical cannabis. The patented Press & Flip closure prevents opening by children's hands. However, it is easy to handle for adults and especially for seniors by pressing and simultaneously folding up the closure. The desiccant integrated into the bottom of the container and the appropriate color selection protect the contents from moisture and light at all times. The integrated pouring assistance ensures hygienic and easy dosing of the drugs.
Related News
-
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News 3 ways ChatGPT will impact pharma marketing teams
What does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers? -
News Eli Lilly, Novo Nordisk, and Sanofi cut insulin prices by up to 78%
Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government. -
News Open letter challenges EU Commission on medicine supply chain
In an open letter to the European Commission, Medicines for Europe calls for a new medicine security contract with their goal to improve access to medicine and ensure a secure supply chain to Europe.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance